Johnson David Ian 4
4 · Enveric Biosciences, Inc. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Johnson David Ian
DirectorCEO and Chairman
Transactions
- Award
Restricted Stock Units
2021-02-15+53,192→ 1,368,999 total→ Common Stock (53,192 underlying) - Award
Restricted Stock Units
2021-02-15+1,315,807→ 1,315,807 total→ Common Stock (1,315,807 underlying)
Footnotes (3)
- [F1]Represents restricted stock units granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan (the "Plan"). For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock upon termination of employment with or services to the Company or in connection with a change of control, as set forth in the reporting person's restricted stock unit award agreement.
- [F2]One-third (1/3rd) of the restricted stock units vested as of December 30, 2020, and the remaining two-thirds (2/3rds) of the restricted stock units shall vest in three equal tranches, with the vesting of each tranche based on the achievement of a performance milestone established by the compensation committee of the board of directors of the Company for such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan.
- [F3]The restricted stock units shall vest in tranches based on the achievement of certain Company and individual performance goals in the 2021 calendar year established by the compensation committee of the board of directors of the Company for each such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan.